Re: Pasquale Rescigno, David Lorente, Diletta Bianchini, et al. Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol 2016;70:724-31

Conteduca Vincenza; Lolli Cristian; De Giorgi Ugo

首页> 外文期刊>European urology >Re: Pasquale Rescigno, David Lorente, Diletta Bianchini, et al. Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol 2016;70:724-31

【24h】

Re: Pasquale Rescigno, David Lorente, Diletta Bianchini, et al. Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol 2016;70:724-31

机译：Re：Pasquale Rescigno，David Lorente，Diletta Bianchini，等。在转移阉割阉割前列腺癌患者的乙酸盐治疗4周后，前列腺特异性抗原下降。 EUR UROL 2016; 70：724-31

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European urology》 |2016年第6期|共2页
作者
Conteduca Vincenza; Lolli Cristian; De Giorgi Ugo;
展开▼
作者单位

Ist Sci Romagnolo Studio &

Cura Tumori IRCCS Via Maroncelli 40 I-47014 Meldola FC Italy;

Ist Sci Romagnolo Studio &

Cura Tumori IRCCS Via Maroncelli 40 I-47014 Meldola FC Italy;

Ist Sci Romagnolo Studio &

Cura Tumori IRCCS Via Maroncelli 40 I-47014 Meldola FC Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献

1. Re: Pasquale Rescigno, David Lorente, Diletta Bianchini, et al. Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol 2016;70:724-31 [J] . Conteduca Vincenza, Lolli Cristian, De Giorgi Ugo European urology . 2016,第6期

机译：回复：Pasquale Rescigno，David Lorente，Diletta Bianchini等。转移性去势抵抗性前列腺癌患者接受醋酸阿比特龙治疗4周后前列腺特异性抗原下降和总体生存率。 Eur Urol 2016; 70：724-31
2. Re: Pasquale Rescigno, David Lorente, Diletta Bianchini, et al. Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol 2016;70:724-31 [J] . Conteduca Vincenza, Lolli Cristian, De Giorgi Ugo European urology . 2016,第6期

机译：Re：Pasquale Rescigno，David Lorente，Diletta Bianchini，等。在转移阉割阉割前列腺癌患者的乙酸盐治疗4周后，前列腺特异性抗原下降。 EUR UROL 2016; 70：724-31
3. Reply to Vincenza Conteduca, Cristian Lolli, and Ugo De Giorgi's Letter to the Editor re: Pasquale Rescigno, David Lorente, Diletta Bianchini, et al. Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol 2016;70:724-31 [J] . Rescigno Pasquale, de Bono Johann S. European urology . 2016,第6期

机译：回复Vincenza Conteduca，Cristian Lolli和Ugo de Giorgi向编辑的信Re：Pasquale Rescigno，David Lorente，Dianta Bianchini，等。在转移阉割阉割前列腺癌患者的乙酸盐治疗4周后，前列腺特异性抗原下降。 EUR UROL 2016; 70：724-31
4. The IMAAGEN Study: Effect of Abiraterone Acetate and Prednisone on Prostate-Specific Antigen and Radiographic Disease Progression in Patients with Non-Metastatic Castration-Resistant Prostate Cancer [O] . Charles J. Ryan, E. David Crawford, Neal D. Shore, -1

机译：IMAAGEN研究：醋酸阿比特龙和泼尼松对非转移性去势抵抗性前列腺癌患者前列腺特异性抗原和放射学疾病进展的影响
5. Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer [O] . Rescigno Pasquale, Lorente David, Bianchini Diletta, 2016

机译：转移性去势抵抗性前列腺癌患者接受醋酸阿比特龙治疗4周后前列腺特异性抗原下降和总体生存率

Re: Pasquale Rescigno, David Lorente, Diletta Bianchini, et al. Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol 2016;70:724-31

著录项

相似文献

相关主题

期刊订阅